COMBINATORIAL BCL-2 FAMILY EXPRESSION IN ACUTE MYELOID LEUKEMIA STEM CELLS PREDICTS CLINICAL RESPONSE TO AZACITIDINE/VENETOCLAX

被引：0
|
作者：
Waclawiczek, A. [1 ,2 ]
Leppa, A. [1 ,2 ]
Renders, S. [1 ,2 ,3 ]
Stumpf, K. [1 ,2 ]
Reyneri, C. [1 ,2 ]
Betz, B. [1 ,2 ]
Janssen, M. [3 ]
Shahswar, R. [4 ]
Donato, E. [1 ,2 ]
Unglaub, J. M. [3 ]
Schlenk, R. F. [3 ]
Hundemer, M. [3 ]
Pabst, C. [3 ]
Heuser, M. [4 ]
Raffel, S. [3 ]
Mueller-Tidow, C. [3 ]
Sauer, T. . [3 ]
Trumpp, A. [1 ,2 ]
机构：
[1] German Canc Res Ctr, Heidelberg, Germany
[2] HiSTEM GmbH, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Heidelberg, Germany
[4] Hannover Med Sch, Hannover, Germany
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
41
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [21] Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia
    Perez, Mauricio
    Barrionuevo, Vanessa
    Arias, Cristina
    Baehring, Joachim M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [22] Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients
    Daneshbod, Y
    Amirghofran, Z
    Tabei, SZ
    NEOPLASMA, 2005, 52 (02) : 109 - 114
  • [23] Effect and Mechanism of NL-101 Combined with Bcl-2 Inhibitor Venetoclax in Acute Myeloid Leukemia
    Jiang, Xia
    Zhuang, Haihui
    Li, Fenglin
    Jiang, Lei
    Jin, Jie
    Lu, Ying
    BLOOD, 2023, 142
  • [24] Haematopoietic response and bcl-2 expression in patients with acute myeloid leukaemia
    Bincoletto, C
    Saad, STO
    da Silva, ES
    Queiroz, MLS
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 62 (01) : 38 - 42
  • [25] Deregulated Bcl-2 Family Expression Drives Chronic Myeloid Leukemia Cancer Stem Cell Survival.
    Goff, Daniel Jacob
    Abrahamsson, Annelie
    Geron, Ifat
    Jamieson, Catriona
    BLOOD, 2008, 112 (11) : 393 - 393
  • [26] Targeting Bcl-2 Proteins in Acute Myeloid Leukemia
    Wei, Yunxiong
    Cao, Yaqing
    Sun, Rui
    Cheng, Lin
    Xiong, Xia
    Jin, Xin
    He, Xiaoyuan
    Lu, Wenyi
    Zhao, Mingfeng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [27] BCL-2 inhibition in Acute Myeloid Leukemia (AML)
    Konopleva, Marina
    Daver, Naval
    DiNardo, Courtney
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S9 - S10
  • [28] High expression of Fas and BCL-2/CD34 in acute myeloid leukemia cells is associated with poor response to chemotherapy
    Min, YH
    Lee, S
    Chong, SY
    Hahn, JS
    Ko, YW
    BLOOD, 1995, 86 (10) : 148 - 148
  • [29] Simultaneous expression of P-glycoprotein and BCL-2 in acute myeloid leukemia (AML) blast cells
    Campos, L
    Oriol, P
    Guyotat, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1286 - 1286
  • [30] The Hyperbolic NAMPT Inhibitor RPT1G Synergizes with BCL-2 Family Inhibitors and Helps Overcome Venetoclax Resistance in Acute Myeloid Leukemia Cells
    Crimmins, Gregory
    Wu, Min
    Roushar, Francis
    Aguilar, Claudia F. Ramos
    Gharghabi, Mehdi
    Cole, Banumathi
    Lapalombella, Rosa
    De Jesus-Diaz, Dennise A.
    BLOOD, 2024, 144 : 4134 - 4135
12345